A case of nonoliguric renal failure after general anesthesia with sevoflurane and desflurane

Anesthesia and Analgesia

Volumn 85, Issue 6, 1997, Pages 1407-1409

  Tung, Avery ^a   Jacobsohn, Eric ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BARA LIME; CALCIUM OXIDE; DESFLURANE; HALOPERIDOL; PAROXETINE; SEVOFLURANE; UNCLASSIFIED DRUG;

ADULT; ANESTHESIA COMPLICATION; ARTICLE; CASE REPORT; DRUG METABOLISM; DRUG SAFETY; GENERAL ANESTHESIA; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; MALE; NEPHROTOXICITY; OLIGURIA; PARANOIA; PRIORITY JOURNAL;

ADULT; ANESTHESIA, GENERAL; ANESTHETICS, INHALATION; ETHERS; HUMANS; ISOFLURANE; KIDNEY FAILURE, ACUTE; MALE; METHYL ETHERS; POSTOPERATIVE COMPLICATIONS;

EID: 0031415603     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199712000-00042     Document Type: Article

References (19)

1. Higuchi H, Sumikura H, Sumita S, et al. Renal function in patients with high serum fluoride concentrations after prolonged sevoflurane anesthesia. Anesthesiology 1995;83:449-58.
2. Mazze RI, Jamison R. Renal effects of sevoflurane [editorial]. Anesthesiology 1995;83:443-5.
3. Morio M, Fujii K, Satoh N, et al. Reaction of sevoflurane and its degradation products with soda lime: toxicity of the byproducts. Anesthesiology 1992;77:1155-64.
4. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of Compound A in rats: effect of a 3 hour administration. Anesthesiology 1994;80:556-65.
5. Gonsowski CT, Laster MJ, Eger EI II, et al. Toxicity of Compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-73.
6. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIFE), in Sprague Dawley rats. Anesthesiology 1995;83: 1220-32.
7. Kandel L, Laster MJ, Eger EI II, et al. Nephrotoxicity in rats undergoing a one-hour exposure to Compound A. Anesth Analg 1995;81:559-63.
8. Eger EI II, Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997;84:160-8.
9. Curreri PW, Luterman A. In: Schwartz SI, Shires TG, Spencer FC, eds. Principles of surgery. New York: McGraw Hill, 1989: 285-305.
10. Novis BK, Roizen MF, Aronson S, Thisted RA. Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg 1994;78:143-9.
11. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983,74:243-8.
12. Swan SK, Bennett WM. Nephrotoxic acute renal failure. In: Lazarus JM, Brenner BM, eds. Acute renal failure. New York: Churchill Livingstone, 1993:357-92.
13. Appel GB, Neu HC. The nephrotoxicity of antimicrobial agents. N Engl J Med 1977;296(2 Pt 3):722-8.
14. Farber BF, Moellering RC Jr. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138-41.
15. Paddock RB, Parker JW, Guadagni NP. The effects of methoxyflurane on renal function. Anesthesiology 1964;25:707-8.
16. Goldberg ME, Cantillo J, Larijani GE, et al. Sevoflurane versus isoflurane for maintenance of anesthesia: are serum inorganic fluoride ion concentrations of concern? Anesth Analg 1996;82: 1268-72.
17. Zager RA. Endotoxemia, renal hypoperfusion, and fever: interactive risk factors for aminoglycoside and sepsis-associated acute renal failure. Am J Kidney Dis 1992;20:223-30.
18. Proctor EA, Barton FL. Polyuric acute renal failure after methoxyflurane and tetracycline. BMJ 1971;4:661-2.
19. Ebert TJ, Muzi M. Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers: a comparison with isoflurane. Anesthesiology 1993;79:444-53.